Management of Ocular Hypertension: A Cost-effectiveness Approach From the Ocular Hypertension Treatment Study
To access this article, please choose from the options below
Supplemental Material available at AJO.com.Supported by Awards to the Washington University School of Medicine Department of Ophthalmology and Visual Sciences from the National Eye Institute, the National Center on Minority Health and Health Disparities, National Institutes of Health (grants EY09341 and EY09307), and unrestricted grants from Merck Research Laboratories and Pfizer, Inc; and by Awards to the Washington University Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness, Inc, and the National Institutes of Health (P30 EY 02687) Core grant.For a complete list of OHTS investigators, please see the OHTS website at https://vrcc.wustl.edu
PII: S0002-9394(06)00039-0
doi:10.1016/j.ajo.2006.01.019
© 2006 Elsevier Inc. All rights reserved.
